Seminars are in Room 366 Library unless otherwise noted.

Tobacco Products and Biomarkers of Tobacco Exposure (Part of "Nicotine: From Addiction to Therapeutics" Series)

Neal L. Benowitz, MD
Professor, Departments of Medicine, Biopharmaceutical Sciences, Psychiatry, and Clinical Pharmacy, UCSF
May 11 2011 - 2:00pm

Dr. Benowitz is interested in the human pharmacology of nicotine, that of nicotine addiction in particular. His recent and current research includes investigations of nicotine's role in controlling cigarette smoking and the use of other forms of tobacco; individual variability in psychological and neuroendocrine responses to nicotine (taking into account gender, ethnicity, age, and genetic factors); the genetics and physiologic pathways of nicotine metabolism, and the pharmacologic activity of nicotine metabolites; innovative therapy approaches to smoking cessation; and interactions between nicotine and illicit stimulant drugs such as methamphetamine and cocaine.

Neal L. Benowitz, MD,Professor, Medicine, Biopharmaceutical Sciences, Psychiatry and Clinical Pharmacy, UCSF Co-Leader, Tobacco Control Program, UCSF Helen Diller Family Comprehensive Cancer Center.

Education:  Rennselaer Polytechnic Institute, Troy, NY. University of Rochester School of Medicine, Rochester, NY, MD, 1969, Medicine.  Bronx Municipal Hospital Center, Bronx, New York, Intern and Resident, Internal Medicine, 1969-1971.  Fellow in Clinical Pharmacology, Department of Medicine, University of California San Francisco, 1971-1973.

Attendance Requirement: 
Required for Year One Fellows